Optimism, Symptom Distress, Illness Appraisal, and Coping in Patients With Advanced-Stage Cancer Diagnoses Undergoing Chemotherapy Treatment

被引:17
|
作者
Sumpio, Catherine [1 ]
Jeon, Sangchoon [2 ]
Northouse, Laurel L. [3 ]
Knobf, M. Tish [2 ]
机构
[1] Smilow Canc Hosp Yale, New Haven, CT 06510 USA
[2] Yale Univ, Sch Nursing, West Haven, CT USA
[3] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
advanced-stage cancer; optimism; stress-coping model; illness appraisal; symptom distress; QUALITY-OF-LIFE; RECURRENT BREAST-CANCER; SOCIAL SUPPORT; FAMILY CAREGIVERS; ORIENTATION TEST; SELF-EFFICACY; WOMEN; PESSIMISM; HEALTH; MODEL;
D O I
10.1188/17.ONF.384-392
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose/Objectives: To explore the relationships between optimism, self-efficacy, symptom distress, treatment complexity, illness appraisal, coping, and mood disturbance in patients with advanced-stage cancer. Design: Cross-sectional study. Setting: Smilow Cancer Hospital at Yale New Haven in Connecticut, an outpatient comprehensive cancer center. Sample: A convenience sample of 121 adult patients with stages III-IV cancer undergoing active chemotherapy. Methods: Participants completed common self-report questionnaires to measure variables. Treatment hours and visits were calculated from data retrieved from medical record review. Mediation and path analysis were conducted to identify direct and indirect pathways from the significant antecedent variables to mood disturbance. Main Research Variables: Dispositional optimism, self-efficacy, social support, treatment complexity, symptom distress, illness appraisal, coping, and mood disturbance. Findings: Greater optimism and self-efficacy were associated with less negative illness appraisal, less avoidant coping, and decreased mood disturbance. Conversely, greater symptom distress was associated with greater negative illness appraisal, greater avoidant coping, and greater mood disturbance. In the final model, optimism and symptom distress had direct and indirect effects on mood disturbance. Indirect effects were partially mediated by illness appraisal. Conclusions: Mood disturbance resulted from an interaction of disease stressors, personal resources, and cognitive appraisal of illness. Avoidant coping was associated with greater disturbed mood, but neither avoidant nor active coping had a significant effect on mood in the multivariate model.
引用
收藏
页码:384 / 392
页数:9
相关论文
共 50 条
  • [21] Safety and efficacy of neoadjuvant chemotherapy with bevacizumab in advanced-stage peritoneal/ ovarian cancer patients
    Kusunoki, Soshi
    Terao, Yasuhisa
    Hirayama, Takashi
    Fujino, Kazunari
    Ujihira, Takafumi
    Ota, Tsuyoshi
    Takeda, Satoru
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2018, 57 (05): : 650 - 653
  • [22] Role of Hormone Receptor Expression in Patients With Advanced-Stage Lung Cancer Treated With Chemotherapy
    Monica, Valentina
    Longo, Marina
    Felice, Barbara
    Scagliotti, Giorgio V.
    Papotti, Mauro
    Novello, Silvia
    CLINICAL LUNG CANCER, 2012, 13 (06) : 416 - 423
  • [23] The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy
    Quist, Morten
    Adamsen, Lis
    Rorth, Mikael
    Laursen, Jorgen H.
    Christensen, Karl B.
    Langer, Seppo W.
    INTEGRATIVE CANCER THERAPIES, 2015, 14 (04) : 341 - 349
  • [24] Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
    Mazzeo, F
    Berlière, M
    Kerger, J
    Squifflet, J
    Duck, L
    D'Hondt, V
    Humblet, Y
    Donnez, J
    Machiels, JP
    GYNECOLOGIC ONCOLOGY, 2003, 90 (01) : 163 - 169
  • [25] Prediction of the survival of patients with advanced-stage ovarian cancer patients undergoing interval cytoreduction with the use of computed tomography reevaluation after neoadjuvant chemotherapy
    Li, Jia-Yi
    Wang, Rui
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (11) : 2700 - 2710
  • [26] Surgical approach for interval debulking after neoadjuvant chemotherapy for treatment of advanced-stage ovarian cancer
    Dugan, K. B.
    McNamara, B.
    Lu, L.
    Litkouhi, B.
    Azodi, M.
    Schwartz, P. E.
    Ratner, E. S.
    Menderes, G.
    Silasi, D. A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 152 - 152
  • [27] Development of a decision aid for primary treatment of patients with advanced-stage ovarian cancer
    den Ouden, Judith E.
    The, Regina
    Myren, Britt J.
    Boll, Dorry
    van Driel, Willemien J.
    Lalisang, Roy, I
    Kruitwagen, Roy F. P. M.
    van Altena, Anne M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (06) : 837 - 844
  • [28] Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer
    Yu, B
    Kusmartsev, S
    Cheng, FD
    Paolini, M
    Nefedova, Y
    Sotomayor, E
    Gabrilovich, D
    CLINICAL CANCER RESEARCH, 2003, 9 (01) : 285 - 294
  • [29] Residual ascites after neoadjuvant chemotherapy decreases treatment response and survival in patients with advanced-stage epithelial ovarian cancer
    Han, K. H.
    Kim, H. S.
    Song, Y. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 710 - 710
  • [30] Physical and psychological distress amongst patients undergoing neoadjuvant chemotherapy for advanced ovarian cancer
    Mokshagundam, Shilpa
    McGree, Michaela E.
    Tapia, Amanda L.
    Fought, Angela J.
    Ishitani, Karen P.
    Lee, Minji K.
    Dowdy, Sean C.
    Yadav, Siddhartha
    Pachman, Deirdre R.
    Kumar, Amanika
    GYNECOLOGIC ONCOLOGY, 2024, 190 : 230 - 235